2型糖尿病患者胰岛中mTOR复合物的相互调节
研究检测2型糖尿病患者胰岛、高糖暴露的人胰岛及INS-1E细胞中mTORC1/2活性,发现糖尿病胰岛mTORC1活性显著升高而mTORC2信号减弱,呈相互调节;抑制mTORC1-S6K1信号可改善糖尿病胰岛及糖尿病小鼠胰岛的葡萄糖刺激胰岛素分泌并恢复mTORC2活性。
要点
- 2型糖尿病患者胰岛mTORC1活性显著升高,mTORC2信号减弱,呈相互调节。
- 高糖(22.2 mmol/l)暴露的人胰岛和β细胞中mTORC1活性升高、mTORC2下调。
- 抑制mTORC1-S6K1信号可改善2型糖尿病及糖尿病小鼠胰岛的葡萄糖刺激胰岛素分泌。
核心结论
- 2型糖尿病患者胰岛、糖尿病相关高糖条件下培养的人胰岛及糖尿病小鼠胰岛均存在mTORC1异常激活,提示mTORC1激活升高是2型糖尿病胰岛的显著病理标志,在代谢应激下参与β细胞功能受损和存活下降。
研究设计与样本
- 研究比较非糖尿病对照与2型糖尿病患者分离的人胰岛,以及暴露于22.2 mmol/l葡萄糖的人胰岛和INS-1E细胞,用western blotting检测mTORC1下游靶点S6K1、S6、4E-BP1及mTORC2下游靶点Akt、NDRG1的磷酸化。
- 用免疫沉淀联合western blotting评估mTORC1/2复合物完整性,用人胰岛切片pS6(Ser 235/236)免疫染色检测激活的mTORC1细胞类型特异性表达。
- 用葡萄糖刺激胰岛素分泌(GSIS)测定β细胞功能,并在2型糖尿病患者胰岛、糖尿病db/db小鼠及高脂/高蔗糖饮食小鼠分离的胰岛中检测抑制mTORC1-S6K1信号的效果。
主要发现
- 2型糖尿病患者胰岛中mTORC1活性显著升高而mTORC2信号减弱,高糖暴露的人胰岛和β细胞中亦见mTORC1活性升高。
- 高糖条件下代谢应激的人胰岛中mTORC1功能上调、mTORC2下调,呈相互调节。
- pS6免疫染色显示2型糖尿病患者胰岛中mTORC1在β细胞特异性上调。
- 抑制mTORC1-S6K1信号改善2型糖尿病患者胰岛及糖尿病db/db小鼠和高脂/高蔗糖饮食小鼠胰岛的GSIS,并恢复mTORC2活性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of nutritional status at the cellular and organismic level. While mTORC1 mediates beta cell growth and expansion, its hyperactivation has been observed in pancreatic islets from animal models of type 2 diabetes and leads to beta cell loss. We sought to determine whether such mTORC1 activation occurs in humans with type 2 diabetes or in metabolically stressed human islets and whether mTORC1 blockade can restore beta cell function of diabetic islets. METHODS: Human islets isolated from non-diabetic controls and individuals with type 2 diabetes, as well as human islets and INS-1E cells exposed to increased glucose (22.2 mmol/l), were examined for mTORC1/2 activity by western blotting analysis of phosphorylation of mTORC1 downstream targets ribosomal protein S6 kinase 1 (S6K1), S6 and eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) and mTORC2 downstream targets Akt and N-myc downstream regulated 1 (NDRG1). mTORC1/2 complexes' integrity was assessed by immunoprecipitation and subsequent western blot analysis. Cell-type specific expression of activated mTORC1 in human islets was examined by immunostaining of pS6 (Ser 235/236) in human islet sections. Beta cell function was measured by glucose-stimulated insulin secretion (GSIS). RESULTS: While mTORC2 signalling was diminished, mTORC1 activity was markedly increased in islets from patients with type 2 diabetes and in islets and beta cells exposed to increased glucose concentrations. Under high-glucose conditions in metabolically stressed human islets, we identified a reciprocal regulation of different mTOR complexes, with functional upregulation of mTORC1 and downregulation of mTORC2. pS6 immunostaining showed beta cell-specific upregulation of mTORC1 in islets isolated from patients with type 2 diabetes. Inhibition of mTORC1-S6K1 signalling improved GSIS and restored mTORC2 activity in islets from patients with type 2 diabetes as well as in islets isolated from diabetic db/db mice and mice fed a high-fat/high-sucrose diet. CONCLUSIONS/INTERPRETATION: Our data show the aberrant mTORC1 activity in islets from patients with type 2 diabetes, in human islets cultured under diabetes-associated increased glucose conditions and in diabetic mouse islets. This suggests that elevated mTORC1 activation is a striking pathogenic hallmark of islets in type 2 diabetes, contributing to impaired beta cell function and survival in the presence of metabolic stress.
引用
- Yuan T, Rafizadeh S, Gorrepati KD, et al. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes. Diabetologia. 2016. PMID: 28004151. doi:10.1007/s00125-016-4188-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。